MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates June 18, 2019
ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.2%
Tue, 18 Jun 12:24 PM
ASTRAZENECA PHARMA share price has zoomed 5% and is presently trading at Rs 1,921.
Meanwhile, the BSE HEALTHCARE Index is at 12,806 (up 0.2%).
Among the top Gainers in the BSE HEALTHCARE Index today is ASTRAZENECA PHARMA (up 5.1%).
STRIDES PHARMA SCIENCE and NARAYANA HRUDAYALAYA LTD are among the top losers today.
Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,415 to Rs 1,921, registering a gain of Rs 506 (up 35.5%).
On the other hand, the BSE HEALTHCARE has moved down from 14,312 to 12,806, loss of 1,506 points (down 10.8%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 62.1%), DIVIS LABORATORIES (up 40.6%) and IPCA LABS (up 36.0%).
What About the Benchmark Indices?
The BSE Sensex is at 39,146 (up 0.3%).
The top gainers among the BSE Sensex stocks today are INDUSIND BANK (up 2.7%), VEDANTA LTD (up 2.6%) and ICICI BANK (up 2.3%). Other gainers include POWER GRID (up 1.8%) and COAL INDIA (up 1.4%). The most traded stocks in the BSE Sensex are SBI and TATA MOTORS.
In the meantime, NSE Nifty is at 11,720 (up 0.4%). ZEE ENTERTAINMENT (up 2.9%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 35,548 to 39,146, registering a gain of 3,598 points (up 10.0%).
ASTRAZENECA PHARMA Financial Update...
ASTRAZENECA PHARMA net profit down at Rs 98 million for the quarter ended March 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 11.6% to Rs 1.9 billion during the period as against Rs 2.2 billion in January-March 2018.
For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.
Revenue of the company grew 4.3% to Rs 6 billion during FY18.
The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 88.1x.
Indian Share Market Update: Top Gainers and Losers
|
| |
Stock Market Updates
Dividend Stocks Amid Volatile Stock Markets; US-China Trade War and More (Today's Market)
Aug 16, 2019 PodcastThe market, which has been caught in the grip of the bears, gave a negative yearly return for first time in last eight years.
Sensex Ends Marginally Higher; Automobile and Power Stocks Witness Buying (Today's Market)
Aug 16, 2019 ClosingThe BSE Sensex ended the day up by 39 points, while the NSE Nifty closed up by 18 points.
PIDILITE INDUSTRIES at All Time High; BSE FMCG Index Up 0.4% (Today's Market)
Aug 16, 2019 03:34 PMPIDILITE INDUSTRIES share price has hit an all time high at Rs 1,373 (up 1.7%). The BSE FMCG Index is up by 0.4%. Among the top gainers in the BSE FMCG Index today are PIDILITE INDUSTRIES (up 1.7%) and P&G HYGIENE (up 0.2%). The top losers include AVANTI FEEDS (down 0.1%) and COLGATE (down 0.1%).
APL APOLLO TUBES Surges by 6%; BSE CAPITAL GOODS Index Down 0.1% (Today's Market)
Aug 16, 2019 03:32 PMAPL APOLLO TUBES share price has surged by 6% and its current market price is Rs 1,350. The BSE CAPITAL GOODS is down by 0.1%. The top gainers in the BSE CAPITAL GOODS Index are APL APOLLO TUBES (up 6.4%) and SUZLON ENERGY (up 6.7%). The top losers are LAKSHMI MACHINE (down 0.2%) and HONEYWELL AUTOMATION (down 0.4%).
CANARA BANK Surges by 5%; BSE BANKEX Index Up 0.8% (Today's Market)
Aug 16, 2019 03:30 PMCANARA BANK share price has surged by 5% and its current market price is Rs 237. The BSE BANKEX is up by 0.8%. The top gainers in the BSE BANKEX Index is CANARA BANK (up 5.2%). The top losers is HDFC BANK (down 0.2%).
ECLERX SERVICES Plunges by 5%; BSE IT Index Down 0.8% (Today's Market)
Aug 16, 2019 03:30 PMECLERX SERVICES share price has plunged by 5% and its current market price is Rs 519. The BSE IT is down by 0.8%. The top gainers in the BSE IT Index are FIRSTSOURCE SOL. (up 3.5%) and ORACLE FINANCIAL (up 3.2%). The top losers is ECLERX SERVICES (down 5.5%).
View More Indian Share Market NewsMost Popular
7 Stocks to Buy in Today's Difficult Market(The 5 Minute Wrapup)
Aug 5, 2019Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.
The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)
Aug 8, 2019This debt-free, well-managed company is all set to soar.
My Top 3 Dividend Millionaire Stocks(Profit Hunter)
Aug 7, 2019As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.
This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)
Aug 12, 2019My experience at the recent AGM of this smallcap company which has financials of any FMCG major.
Qatar is Rearing Cows...this is Good News for India
Aug 9, 2019Qatar has turned around after the Saudi embargo. This is good news for India.
More|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!